Prognostic role of EGR1 in breast cancer: a systematic review

EGR1 (early growth response 1) is dysregulated in many cancers and exhibits both tumor suppressor and promoter activities, making it an appealing target for cancer therapy. Here, we used a systematic multiomics analysis to review the expression of EGR1 and its role in regulating clinical outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Subbroto Kumar, Islam, S. M. Riazul, Saha, Tripti, Nishat, Afsana, Biswas, Polash Kumar, Gil, Minchan, Nkenyereye, Lewis, El-Sappagh, Shaker, Islam, Md. Saiful, Cho, Ssang-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2021
Materias:
Invited Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560464/
https://www.ncbi.nlm.nih.gov/pubmed/34488929
http://dx.doi.org/10.5483/BMBRep.2021.54.10.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560464/
https://www.ncbi.nlm.nih.gov/pubmed/34488929
http://dx.doi.org/10.5483/BMBRep.2021.54.10.087

Ejemplares similares